Galcanezumab safe and effective for chronic migraine and medication overuse headacheJune 20, 2023Headache & Migraine
Ketogenic diet may improve sleep complaints in patients with migraineJune 20, 2023Headache & Migraine
Fremanezumab switch may benefit migraine patients who are not responding to anti-CGRP mAbJune 20, 2023Headache & Migraine
Real-world data show benefits of anti-CGRP mAb in migraine patients age ≥ 65 yearsJune 20, 2023Headache & Migraine
Perimenstrual migraine attacks are exclusively migraine attacks without aura, recommends studyJune 20, 2023Headache & Migraine
Efficacy of galcanezumab after 1 week of treatment for migraine predicts responders at 3 monthsJune 20, 2023Headache & Migraine
Concomitant oral preventive treatment may dampen response in chronic migraine treated with onabotulinumtoxinAJune 20, 2023Headache & Migraine
Commentary: CGRP medications, COVID-19, and menopause in patients with migraine, June 2023May 31, 2023Headache & Migraine
